Click image to enlarge
The R-PLEX platform offers matched sets of antibodies and calibrators for a wide menu of biomarkers. The R-PLEX Mouse HAVCR1/KIM-1 Antibody Set can be used with other MSD components (see "Recommended Components" tab below) to build assays that measure HAVCR1/KIM-1. These assays can measure HAVCR1/KIM-1 alone or in multiplex panels with other biomarkers.
The Product Inserts for R-PLEX Antibody Sets provide detailed instructions for building assays in several formats. The datasheet for HAVCR1/KIM-1 provides specific information for the components (including calibrator stock concentration), recommended sample types and dilution factors, and representative data for analytical performance. These items and other helpful documents can be found in the "Documentation" tab below.
Related Key Terms
HAVCR1, Kidney injury molecule-1, KIM-1, TIM-1
-
Specifications
-
Recommended Components
-
Kit Contents
-
Documentation
-
References
Application(s)
|
|
Oncology & Cancer
|
|
Analyte(s)
|
|
HAVCR1/KIM-1
|
|
Species
|
|
Mouse
|
|
LLOD (Sensitivity)
|
|
20.9
|
|
Dynamic Range
|
|
20.9-30,000
|
|
Sample Type
|
|
Plasma, Serum
|
|
Usage Statement
|
|
For Research Use Only. Not for use in diagnostic procedures.
|
|
Storage Condition
|
|
Multi-Component
|
|
Gene ID(s)
|
|
171283
|
|
UniProt ID(s)
|
|
Q5QNS5
|
|
Assay Diluent(s)
|
|
Diluent 41
|
|
Antibody Diluent(s)
|
|
Diluent 45
|
|
Schedule B Code
|
|
3822.19.0000
|
|
Why do I need other components
Catalog No.
Product Name
Size
R50AI-1
R60AM-1
L45SA-1
Product Description
|
Storage
|
Quantity per Kit
|
Mouse HAVCR1/KIM-1 Antibody Set
|
2-8 °C
|
1 each (5 plate size)
|
|
Mouse HAVCR1/KIM-1 Calibrator
|
≤-70 °C
|
5 vial (1 vial)
|
|
Product Inserts
|
|
|
Datasheets
|
|
|
Handouts
|
|
|
SDS
|
|
|
Title
|
Journal
|
Year
|
|
Glyoxalase-1 overexpression reduces endothelial dysfunction and attenuates early renal impairment in a rat model of diabetes.
|
|
|
|
Urinary biomarkers track the progression of nephropathy in hypertensive and obese rats.
|
|
|
|
Application of emerging biomarkers of acute kidney injury in development of kidney-sparing polypeptide-based antibiotics.
|
|
|
|
Assessment of cisplatin-induced kidney injury using an integrated rodent platform.
|
|
|
|
Early prediction of polymyxin-induced nephrotoxicity with next generation urinary kidney injury biomarkers.
|
|
|
|
View All
|
Order Details
Catalog No
Size
Price in USD
Qty
Customer Service/Orders
Scientific/Technical Support
Instrument Support
Company Headquarters